Rapid Therapeutic Science Lab inc
Rapid Therapeutic Science Laboratories, Inc. focuses on developing potential commercial opportunities which involve the rapid application of therapeutics using inhaler technology. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013… Read more
Rapid Therapeutic Science Lab inc (RTSL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: 0.003x
Based on the latest financial reports, Rapid Therapeutic Science Lab inc (RTSL) has a cash flow conversion efficiency ratio of 0.003x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.33K) by net assets ($-2.74 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Rapid Therapeutic Science Lab inc - Cash Flow Conversion Efficiency Trend (2012–2022)
This chart illustrates how Rapid Therapeutic Science Lab inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Rapid Therapeutic Science Lab inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rapid Therapeutic Science Lab inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Daesung Energy Co. Ltd.
KQ:117580
|
N/A |
|
YOC (YOC.SG)
STU:YOC
|
0.130x |
|
Valamar Riviera d.d.
ZSE:RIVP
|
N/A |
|
AVINO SILVER & GOLD
MU:GV6
|
0.010x |
|
Atos SE
PINK:AEXAF
|
-0.311x |
|
ITUB3F
SA:ITUB3F
|
N/A |
|
Mmcité a.s.
PR:MMCTE
|
N/A |
|
Soiltech ASA
OL:STECH
|
0.206x |
Annual Cash Flow Conversion Efficiency for Rapid Therapeutic Science Lab inc (2012–2022)
The table below shows the annual cash flow conversion efficiency of Rapid Therapeutic Science Lab inc from 2012 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $-3.14 Million | $-1.15 Million | 0.367x | -77.07% |
| 2021-12-31 | $-1.38 Million | $-2.21 Million | 1.599x | +1945.24% |
| 2019-12-31 | $-1.36 Million | $-106.66K | 0.078x | +72.33% |
| 2018-12-31 | $-2.86 Million | $-129.85K | 0.045x | 0.00% |
| 2018-03-31 | $-2.86 Million | $-129.85K | 0.045x | -95.24% |
| 2017-12-31 | $-22.91K | $-21.84K | 0.954x | -88.56% |
| 2016-03-31 | $-1.29K | $-10.74K | 8.334x | 0.00% |
| 2015-12-31 | $-1.29K | $-10.74K | 8.334x | +2958.03% |
| 2014-12-31 | $46.07K | $-13.43K | -0.292x | -22.45% |
| 2012-12-31 | $83.98K | $-20.00K | -0.238x | -- |